ASMB
Price
$20.23
Change
+$0.56 (+2.85%)
Updated
Oct 27, 04:54 PM (EDT)
Capitalization
400.49M
13 days until earnings call
Intraday BUY SELL Signals
SGMT
Price
$10.43
Change
+$0.87 (+9.10%)
Updated
Oct 27, 04:59 PM (EDT)
Capitalization
594.24M
16 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ASMB vs SGMT

ASMB vs SGMT Comparison Chart in %
View a ticker or compare two or three
VS
ASMB vs. SGMT commentary
Oct 27, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASMB is a StrongBuy and SGMT is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ASMB with price predictions
Oct 26, 2026

ASMB's RSI Indicator is remaining in oversold zone for 1 day

It is expected that a price bounce should occur soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Moving Average Convergence Divergence (MACD) for ASMB just turned positive on October 20, 2026. Looking at past instances where ASMB's MACD turned positive, the stock continued to rise in 31 of 42 cases over the following month. The odds of a continued upward trend are 74%.

Following a +5.47% 3-day Advance, the price is estimated to grow further. Considering data from situations where ASMB advanced for three days, in 215 of 269 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

ASMB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The 10-day moving average for ASMB crossed bearishly below the 50-day moving average on September 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 16 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

The 50-day moving average for ASMB moved below the 200-day moving average on October 23, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ASMB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.

The Aroon Indicator for ASMB entered a downward trend on October 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 79 (best 1 - 100 worst), indicating slightly worse than average price growth. ASMB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.310) is normal, around the industry mean (3.037). P/E Ratio (15.863) is within average values for comparable stocks, (-1.223). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (135.883) among similar stocks. P/S Ratio (5.568) is also within normal values, averaging (439.237).

The Tickeron SMR rating for this company is 89 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ASMB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for SGMT with price predictions
Oct 26, 2026

SGMT's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for SGMT turned positive on October 20, 2026. Looking at past instances where SGMT's MACD turned positive, the stock continued to rise in 30 of 31 cases over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where SGMT's RSI Indicator exited the oversold zone, 16 of 18 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 89%.

The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on SGMT as a result. In 47 of 53 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 89%.

Following a +12.75% 3-day Advance, the price is estimated to grow further. Considering data from situations where SGMT advanced for three days, in 152 of 179 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.

SGMT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

SGMT moved below its 50-day moving average on October 22, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for SGMT crossed bearishly below the 50-day moving average on October 05, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 7 of 7 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SGMT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.

The Aroon Indicator for SGMT entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 20 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.320) is normal, around the industry mean (3.037). P/E Ratio (-7.587) is within average values for comparable stocks, (-1.223). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (135.883) among similar stocks. P/S Ratio (75.758) is also within normal values, averaging (439.237).

The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. SGMT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 80 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SGMT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
ASMB: Fundamental Ratings
ASMB
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
89
PRICE GROWTH RATING
1..100
79
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ASMBSGMT
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 8 days ago
80%
Bullish Trend 7 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
85%
COMPARISON
Comparison
Oct 27, 2026
Stock price -- (ASMB: $19.67 vs. SGMT: $9.56)
Brand notoriety: ASMB and SGMT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ASMB: 51% vs. SGMT: 48%
Market capitalization -- ASMB: $400.49M vs. SGMT: $594.24M
ASMB [@Biotechnology] is valued at $400.49M. SGMT’s [@Biotechnology] market capitalization is $594.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $131.16B. The average market capitalization across the [@Biotechnology] industry is $2.12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASMB’s FA Score shows that 0 FA rating(s) are green while SGMT’s FA Score has 1 green FA rating(s).

  • ASMB’s FA Score: 0 green, 5 red.
  • SGMT’s FA Score: 1 green, 4 red.
According to our system of comparison, SGMT is a better buy in the long-term than ASMB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASMB’s TA Score shows that 5 TA indicator(s) are bullish while SGMT’s TA Score has 5 bullish TA indicator(s).

  • ASMB’s TA Score: 5 bullish, 4 bearish.
  • SGMT’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ASMB is a better buy in the short-term than SGMT.

Price Growth

ASMB (@Biotechnology) experienced а -2.43% price change this week, while SGMT (@Biotechnology) price change was +7.90% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.32%. For the same industry, the average monthly price growth was -10.69%, and the average quarterly price growth was -13.52%.

Reported Earning Dates

ASMB is expected to report earnings on Nov 09, 2026.

SGMT is expected to report earnings on Nov 12, 2026.

Industries' Descriptions

@Biotechnology (+4.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ASMB
Daily Signal:
Gain/Loss:
SGMT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

ASMB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASMB has been loosely correlated with ENTA. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ASMB jumps, then ENTA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASMB
1D Price
Change %
ASMB100%
-0.86%
ENTA - ASMB
43%
Loosely correlated
+3.09%
FDMT - ASMB
42%
Loosely correlated
+2.13%
VYGR - ASMB
42%
Loosely correlated
+0.57%
EDIT - ASMB
41%
Loosely correlated
N/A
IMMX - ASMB
41%
Loosely correlated
-1.10%
More

SGMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SGMT has been loosely correlated with VIR. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if SGMT jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGMT
1D Price
Change %
SGMT100%
-0.21%
VIR - SGMT
41%
Loosely correlated
+4.45%
EDIT - SGMT
40%
Loosely correlated
N/A
IMNM - SGMT
38%
Loosely correlated
-0.56%
ASMB - SGMT
37%
Loosely correlated
-0.86%
IMTX - SGMT
37%
Loosely correlated
-2.19%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EROK19.671.43
+7.84%
EagleRock Land LLC
NWGL0.090.01
+5.98%
CL Workshop Group Limited
FRO55.232.29
+4.33%
Frontline Plc
HYPR0.72N/A
-0.17%
Hyperfine
FLYW19.15-0.25
-1.29%
Flywire Corp